- Phare
- Validé par KD/KO
Anticorps Recombinant de lapin anti-TGF Beta 1
TGF Beta 1 Recombinant Antibody for WB, IHC, IF/ICC, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris et plus (1)
Applications
WB, IHC, IF/ICC, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
230544B7
N° de cat : 81746-2-RR
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A549, cellules 4T1, cellules C6, cellules HepG2, cellules HL-60, cellules K-562, cellules L-929, cellules RAW 264.7, tissu splénique de souris |
Résultats positifs en IHC | tissu pulmonaire de souris, il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF/ICC | cellules HEK-293, |
Résultats positifs en FC (Intra) | cellules HEK-293, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunohistochimie (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 11 publications below |
IHC | See 4 publications below |
IF | See 2 publications below |
Informations sur le produit
81746-2-RR cible TGF Beta 1 dans les applications de WB, IHC, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | rat, Humain, Lapin, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | TGF Beta 1 Protéine recombinante Ag13591 |
Nom complet | transforming growth factor, beta 1 |
Masse moléculaire calculée | 44 kDa |
Poids moléculaire observé | 44 kDa |
Numéro d’acquisition GenBank | BC000125 |
Symbole du gène | TGFB1 |
Identification du gène (NCBI) | 7040 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TGF Beta 1 (TGF-β1) is a pleiotropic cytokine and a member of the TGF-β superfamily (including TGF-β1, TGF-β2, and TGF-β3). It is encoded by the TGFB1 gene and acts as a secreted protein involved in controlling cell growth, proliferation, differentiation, and apoptosis. TGF-β1 is produced by various cell types (e.g., platelets, lymphocytes, macrophages, epithelial cells, and inflammatory cells) and is secreted as a precursor requiring proteolytic activation to yield the mature, biologically active peptide. TGF-β1 plays crucial roles in immune regulation, wound healing, fibrosis, and tissue remodeling (including cardiac injury and fibrosis). It also influences cancer progression by promoting epithelial-to-mesenchymal transition (EMT) and metastasis in tumors.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for TGF Beta 1 antibody 81746-2-RR | Download protocol |
IHC protocol for TGF Beta 1 antibody 81746-2-RR | Download protocol |
IF protocol for TGF Beta 1 antibody 81746-2-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Free Radic Biol Med N6-methyladenosine modification of SPOP relieves ferroptosis and diabetic cardiomyopathy by enhancing ubiquitination of VDAC3 | ||
J Orthop Surg Res Regeneration process of severed rabbit common calcanean tendons influenced by external compression | ||
Life (Basel) Anticancer Effects of Weizmannia coagulans MZY531 Postbiotics in CT26 Colorectal Tumor-Bearing Mice by Regulating Apoptosis and Autophagy | ||
J Ethnopharmacol New idea of Fuke Qianjin capsule in treating sequelae of pelvic inflammatory disease: anti-inflammatory in the early stage and reparative in the later stage | ||
Front Immunol Acute hypoxia modulate macrophage phenotype accompanied with transcriptome re-programming and metabolic re-modeling | ||
Urolithiasis Inhibition of NLRP3 alleviates calcium oxalate crystal-induced renal fibrosis and crystal adhesion |